Description: -A unique collection of 53200 approved and clinical drugs for high throughput screening (HTS) ;-Covers 300+ targets and over 500 sub-libraries of specific-targeted compounds, suitable for diverse screening purposes.-Over 1,900 compound scaffolds and 600+ unique heterocyclic structures for enhanced screening probability and novelty.-Rigorous multi-filter screening ensures each sub-library contains 25-250 compounds with good drug-like properties.-NMR and HPLC validated to ensure high purity and quality.-Multiple specifications are available, including 200μL * 10mM (in DMSO), 100 μL* 10mM (in DMSO) etc.